Action AGTC APPLIED GENETIC TECHNOLOGIES CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Applied Genetic Technologies Corporation

Actions

AGTC

US03820J1007

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Adrenoleukodystrophy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
Applied Genetic Technologies : Termination of Material Agreement - Form 8-K
APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation
Syncona's Achilles says cancer treatment shows promise; seals buy
British Investor Syncona Closes Acquisition of US Biotech Applied Genetic Technologies
Applied Genetic Technologies Corporation(NasdaqGM:AGTC) dropped from NASDAQ Composite Index
Syncona Limited, a fund managed by Syncona Investment Management Limited completed the acquisition of Applied Genetic Technologies Corporation.
APPLIED GENETIC TECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits (form 8-K)
Applied Genetic Technologies Says Syncona Extends Tender Offer Through Wednesday
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation
TOP NEWS: AstraZeneca to buy Neogene for cancer treatment
Syncona Extends Offer Period For $24 Million Takeover of Applied Genetic Technologies
Applied Genetic Technologies Corporation(NasdaqGM:AGTC) dropped from S&P TMI Index
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*
APPLIED GENETIC TECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits (form 8-K)
*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AGTC
  4. Actualités Applied Genetic Technologies Corporation
  5. Autres langues